Form D — Accipiter Biosciences Inc.
0001973963-26-000002 · filed Jul 28, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $10,492,778
- Total sold
- $10,492,778
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Accipiter Biosciences Inc.
- CIK
- 1973963
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 1616 EASTLAKE AVE E.
SEATTLE, WA 98102 - Phone
- 212-472-6343
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Matthew Bick · Executive OfficerSeattle, WA Find on LinkedIn ↗
-
Hector De Jesus Rincon Arano · Executive OfficerSeattle, WA Find on LinkedIn ↗
-
Javier Castellanos · Executive OfficerSeattle, WA Find on LinkedIn ↗
-
Heather Redman · DirectorSeattle, WA Find on LinkedIn ↗
-
Randall Schatzman · DirectorSeattle, WA Find on LinkedIn ↗
-
William Canestaro · Executive OfficerSeattle, WA Find on LinkedIn ↗
-
Jose Antonio Mesa Cejudo · DirectorSeattle, WA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗